ACQUIRED · 2018
Who Acquired ProVation Medical?
Clearlake Capital Group, LP · $180.0M· 6.0× EBITDA
The acquisition
ProVation Medical was acquired by Clearlake Capital Group, LP in 2018 for $180.0M. The deal was priced at 6.0× EBITDA / 2.30× revenue.
ProVation Medical at time of acquisition
Revenue
$78.0M
EBITDA
$30.0M
Deal value
$180.0M
EV / EBITDA
6.0×
Other acquisitions by Clearlake Capital Group, LP
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- nThrive RCM Technology Division · 2020 · $1.00B · 10.0× EBITDA
Similar healthcare it acquisitions
- Eucalyptus · acquired by Hims & Hers Health, Inc. in 2026 · $1.15B
- Gleamer SAS · acquired by RadNet, Inc. in 2026 · $251.6M
- HealthEZ · acquired by Blue Cross Blue Shield of New Jersey in 2026 · $360.0M
- Unbound Medicine · acquired by MPS Ltd in 2026 · $16.5M
- AccessOne · acquired by Phreesia, Inc. in 2025 · $160.0M
Run a valuation for a similar healthcare it business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the healthcare it calculator →More on healthcare it valuations
- Healthcare It valuation calculator· head-term variant
- Healthcare It median multiples· real-deal benchmarks
- How to value a healthcare it· long-form guide
Sourced from Press releases. Full deal page.
Citation: ExitValue.ai. (2018). ProVation Medical acquired by Clearlake Capital Group, LP. https://exitvalue.ai/acquired/provation-medical